Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Executive Officer, Director
-
Stock Symbol
-
MNPR on Nasdaq
There are no Buy or Sell transactions made by Chandler Robinson since 12/23/2023
Holdings reported by Chandler Robinson for Monopar Therapeutics
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
56.2K |
$379K |
$6.74 |
Sep 30, 2024 |
Direct |
|
|
| Common Stock |
33.3K |
$225K |
$6.74 |
Sep 30, 2024 |
Indirect |
|
|
| Restricted Stock Units |
29.8K |
$201K |
$6.74 |
Sep 30, 2024 |
Direct |
Common Stock |
|
| Stock Options |
0 |
|
|
May 28, 2024 |
Direct |
Common Stock |
|
Transactions reported by Chandler Robinson for Monopar Therapeutics
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.